| |
| |
|
| Insider
Information: |
Bozic Carmen |
| Relationship: |
EVP and CMO |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,939 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$14,682,514 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,939 |
|
|
| Total
Value |
$14,682,514 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP and CMO |
2024-02-23 |
36,939 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$1,428,793 |
D/D |
(3,309) |
36,939 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$1,182,671 |
D/D |
(2,812) |
40,248 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,590,038 |
D/D |
(3,750) |
43,060 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$887,754 |
D/D |
(2,100) |
46,810 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
5,928 |
48,910 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,680 |
42,982 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-11-14 |
4 |
AS |
$380.82 |
$2,151,633 |
D/D |
(5,650) |
29,302 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-10-31 |
4 |
AS |
$355.92 |
$2,011,304 |
D/D |
(5,651) |
34,952 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-10-17 |
4 |
AS |
$373.25 |
$2,109,236 |
D/D |
(5,651) |
40,603 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-10-03 |
4 |
AS |
$345.28 |
$1,951,177 |
D/D |
(5,651) |
46,254 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-09-19 |
4 |
AS |
$351.00 |
$1,983,501 |
D/D |
(5,651) |
51,905 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-09-05 |
4 |
AS |
$352.66 |
$1,992,882 |
D/D |
(5,651) |
57,556 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-02-24 |
4 |
D |
$289.12 |
$956,409 |
D/D |
(3,308) |
63,207 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-02-17 |
4 |
D |
$292.85 |
$1,098,188 |
D/D |
(3,750) |
66,515 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-02-13 |
4 |
D |
$298.26 |
$1,488,914 |
D/D |
(4,992) |
70,265 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-02-10 |
4 |
D |
$294.33 |
$796,751 |
D/D |
(2,707) |
75,257 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,452 |
77,964 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2022-05-31 |
4 |
D |
$271.24 |
$84,356 |
D/D |
(311) |
49,512 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2022-02-24 |
4 |
D |
$227.86 |
$283,002 |
D/D |
(1,242) |
49,823 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2022-02-17 |
4 |
D |
$232.51 |
$799,602 |
D/D |
(3,439) |
51,065 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2022-02-10 |
4 |
D |
$237.74 |
$579,372 |
D/D |
(2,437) |
54,504 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2022-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,988 |
56,941 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2021-05-28 |
4 |
D |
$210.04 |
$65,322 |
D/D |
(311) |
32,953 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2021-02-24 |
4 |
D |
$217.57 |
$67,664 |
D/D |
(311) |
33,264 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP and CMO |
• – – |
2021-02-10 |
4 |
D |
$214.16 |
$506,917 |
D/D |
(2,367) |
33,575 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
